Editor's Pick

House GOP escalates war on Justice Dept. as members flock to Trump trial

The Republican chairs of the powerful House Judiciary and Oversight committees slammed the Biden administration this week, accusing the president and Attorney General Merrick Garland of politicizing the justice system.

But as Reps. Jim Jordan (R-Ohio) and James Comer (R-Ky.) pilloried the White House and the Justice Department, their committees were hobbled by attendance problems: At least five members were in New York on Thursday morning, standing behind former president Donald Trump at his criminal trial and inserting themselves, and their political views, into the same justice system the two chairmen claimed to be defending from politicization.

This post appeared first on The Washington Post

You May Also Like

Stock

In this edition of StockCharts TV‘s The Final Bar, Dave shows how breadth conditions have evolved so far in August, highlights the renewed strength in the...

Stock

Major equity indexes rose on Friday after a selloff that hit the Technology sector especially hard. But this doesn’t necessarily mean that everything is...

Latest News

President Joe Biden travels to Triangle, Virginia, Monday to mark Earth Day, where he’ll unveil $7 billion in grant funding for solar power under...

Latest News

Britain’s Prince and Princess of Wales have released a new photo of Prince Louis to mark his sixth birthday on Tuesday, the first image...

Disclaimer: Dealwithbiz.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Dealwithbiz.com